Category: Social
-
Dead Astronauts raises 4 MEUR
(Malmö, developing an open-world action-adventure game): Has raised 4 MEUR in a funding round from Behold Ventures with member Karl-Magnus Troedsson, Lifelike Capital, 1Up Ventures, Acequia Capital, Are Mack Growen, Matt Bilbey, Klaas Kersting, Asbjoern Malte Soendergaard GDC, and Kristian Segerstrale. “We see immense opportunities to reinvent open worlds and push game-changing technology,” comments Erik Morin.
-
Recarber raises 60 MSEK
(Stockholm, a platform for capturing and storing carbon dioxide – and selling credits to large corporations): Has raised 60 MSEK in a funding round from Luminar Ventures with members Louise Hagen and Magnus Bergman, Spintop Ventures with member Peter Carlsson, and Course Corrected with members Christine Ahlstrand and Kerstin Cooley. “We hope to bring our first project to an investment decision early next year. It will likely involve either a combined heat and power plant or…
-
Gesynta Pharma raises 26.5 MEUR
(Stockholm, is developing a drug candidate for the treatment of endometriosis): Has raised 26.5 MEUR in a funding round led by Innovestor Life Science, with participation from Hadean Ventures, Linc, Foreground Capital, Catalyze Capital, Stephen Industries, Amboy Street Ventures, and Industrifonden with member Peter Wolpert. The funding will support a Phase II clinical trial in Europe.
-
Vaja raises 4.35 MSEK
(Stockholm, wind-adaptive technology for solar parks): Has raised 4.5 MSEK in a funding round from Node.vc with founding member John Elvesjö and members Daniela Sjunnesson, Rebecca Sjödin, Mårten Skogö, Henrik Tellving, and Andy Johnston. “We have a humble ambition to revolutionize the global solar park market,” comments Henrik Eskilsson.
-
Marshall is acquired by Hongshan
(Stockholm, premium audio products, including headphones and speakers): Has been acquired by Hongshan in a deal that valued Marshall at around 13 billion SEK. Altor, with member Andreas Källström Säfweräng, held a majority stake in Marshall. “It’s a bit faster than usual. We can keep the companies for 15 years, but sometimes things can move…
-
Open Payments raises 3 MEUR
(Stockholm, provides an open banking solution that connects financial management systems with multiple banks): Has raised 3 MEUR in a funding round led by Alfvén & Didrikson, with participation from Industrifonden with member Peter Wolpert and existing investors. “Our ability to combine open banking and ISO integrations in one API is what sets us apart,” comments Louise Brandt.
-
Carla raises 38 MSEK
(Stockholm, a marketplace for electric cars and plug-in hybrids): Has raised 38 MSEK in a funding round from existing investors. Early investors in Carla include founding member Karl-Johan Persson and member Paul Fischbein, as well as Inbox with founding member Martin Wattin and Luminar Ventures with members Louise Hagen and Magnus Bergman. Carla was valued at 330 million in the round.
-
Keystone Education Group secures 100 MEUR
Oslo, helping education institutions reach, recruit and enroll prospective students): Has secured a bond issue of 100 MEUR from a group of institutional investors. Early founders of Keystone include members Fredrik Söderlindh and Mattias Säker alongside founding member Marcus Boström. Today, a world leader, Keystone helps students from over 190 countries connect with more than 5.000 educational institutions.
-
Easypark acquires Flowbird
(Stockholm, offers smart parking solutions, helping drivers find, pay for, and reserve parking through its app): Has acquired Flowbird for an undisclosed amount. Early investors in Easypark include founding member Tuva Palm. “This day marks a step towards improving the utilization of spaces worldwide. Our even broader offering will enable our customers to optimize mobility…
-
AnaCardio raises 19 MUSD
(Stockholm, develops novel drugs to treat heart failure): Has raised 19 MUSD in a funding round from Novo Holdings, Pureos Bioventures, Sound Bioventures, Flerie, Fredrik andAnn-Helene Ljungström alongside Industrifonden with member Peter Wolpert. “We now have the data and funding to accelerate the further clinical development of our first-in-class inotrope to improve the lives of patients with heart failure,” comments…